drugset / Trial / NCT07246187
Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The aim of the study is to identify which medication (haloperidol or olanzapine) is most effective in treating nausea and abdominal pain associated with cannabinoid hyperemesis using a 10-point visual analog scale with intervals of 0.5.
Timeline
- Start
- 2025-11-06
- Primary completion
- 2026-10-31
- Completion
- 2026-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | 5 mg | Intramuscular |
| Comparator | Olanzapine | Small molecule | 10 mg | Intramuscular |